IBER
Ibere Pharmaceuticals
IBER
IBER
Delisted
IBER was delisted on the 1st of March, 2023.
38 hedge funds and large institutions have $71.4M invested in Ibere Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+6
Holders Change %
+18.75%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
4
Closed
–
Calls
$89K
Puts
–
Net Calls
+$89K
Net Calls Change
+$15K
Top Buyers
1 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
$2.46M |
2 |
Citadel Advisors
Miami,
Florida
|
$7.53M |
3 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
$1.65M |
4 |
D.E. Shaw & Co
New York
|
$1.57M |
5 |
SSA
Schonfeld Strategic Advisors
New York
|
$1.31M |
Top Sellers
1 |
OPU
Omni Partners US
Irvine,
California
|
$567K |
2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
$5.98M |
3 |
GCL
Glazer Capital LLC
New York
|
$103K |
4 |
AM
Ampfield Management
New York
|
$432K |